> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Adverse Event Reporting During Pandemic
- URL: https://www.fdaweb.com/comments-sought-on-adverse-event-reporting-during-pandemic/
- Published: 2017-11-01T12:00:00.000Z
- Updated: 2026-09-14T22:59:30.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5140023

*Federal Register* notice: FDA is seeking comments on an information collection extension on the “Guidance for Industry on Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic.” The guidance includes recommendations for planning, notification, and documentation for firms that report postmarketing adverse events. The guidance recommends that each firm’s pandemic influenza continuity of operations plan include instructions for reporting adverse events, including a plan for the submission of stored reports that were not submitted within regulatory timeframes. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-10-31/pdf/2017-23659.pdf?ref=fdaweb.com).